Acorai: Funding, Investors & Team (Sep 2026)
Acorai is working on a non-invasive device called the Acorai Heart Monitor, designed to manage heart failure by monitoring intracardiac pressure. This device aims to decrease the need for hospitalizations and readmissions. It employs machine learning to analyze data from acoustics, vibrations, and waveforms to accurately measure intracardiac pressures. Our technology is precise, carries minimal clinical and regulatory risks, does not heavily rely on reimbursement, and can be expedited for commercial availability.
Acorai has raised $11.4M across 4 funding rounds on record, the most recent an undisclosed round of $4.4M announced in Dec 2024.
That round is in line with the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Acorai Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Acorai Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
Acorai announced an undisclosed round in Jul 2023; the amount was not disclosed.
4 months later, an undisclosed round of $2.5M was announced in Nov 2023.
2 months later, a Seed of $4.5M was announced in Jan 2024.
11 months later, an undisclosed round of $4.4M was announced in Dec 2024.
Acorai Founders and Leadership Team
Contact details for the Acorai team: 3 of 3 have an email address on file.
Start 14-day free trial →Acorai Funding Compared to Other Health Care Startups
Acorai's latest round of $4.4M is in line with the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Acorai in Health Care and Helsingborg
Companies Similar to Acorai
Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have…
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the…
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and…
Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…
B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…
Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company…
Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…
Acorai Funding FAQs
What does Acorai do?
Acorai is working on a non-invasive device called the Acorai Heart Monitor, designed to manage heart failure by monitoring intracardiac pressure. This device aims to decrease the need for hospitalizations and readmissions. It employs machine learning to analyze data from acoustics, vibrations, and waveforms to accurately measure intracardiac pressures. Our technology is precise, carries minimal clinical and regulatory risks, does not heavily rely on reimbursement, and can be expedited for commercial availability.
How much funding has Acorai raised?
Acorai has raised $11.4M across 4 rounds on record. The most recent is an undisclosed round of $4.4M announced in Dec 2024.
When did Acorai last raise funding?
Acorai's most recent funding round on record is an undisclosed round of $4.4M, announced in Dec 2024.
Who founded Acorai?
FundedIQ lists Filip Peters (Founder), Jakob Gelberg (Founder), Kasper Bourdette (Founder) at Acorai.
Where is Acorai headquartered?
Acorai is based in Helsingborg, Skane Lan, Sweden.
How many employees does Acorai have?
Acorai is in the 11-50 employee band.
How does Acorai's funding compare to other Health Care startups?
Acorai's latest round of $4.4M is in line with the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Acorai Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acorai is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.